Ifm Therapeutics (United States)
ORCID: 0000-0003-2265-3363Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation”.
Joyca De Temmerman, Tasuku Kitada, Jacob Becraft, Ron Weiss, Darrell J. Irvine +5 more